AJP - Heart pressure measurements
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 284: H619-H625, 2003. First published October 10, 2002; doi:10.1152/ajpheart.00110.2002
0363-6135/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
284/2/H619    most recent
00110.2002v2
00110.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Birk, A. V.
Right arrow Articles by Szeto, H. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Birk, A. V.
Right arrow Articles by Szeto, H. H.
Vol. 284, Issue 2, H619-H625, February 2003

Interaction between ATP and catecholamines in stimulation of platelet aggregation

Alex V. Birk1,2, Endri Leno3, Hugh D. Robertson2, Victoria M. Bolotina3, and Hazel H. Szeto1

Departments of 1 Pharmacology and 2 Biochemistry, Weill Medical College of Cornell University, New York, New York 10021; and 3 Department of Physiology, Boston University School of Medicine, Boston, Massachusetts 02118-2393

Platelets, on activation by endothelial damage, release ADP, ATP, serotonin, epinephrine, and norepinephrine. Although ATP is known to augment the action of norepinephrine in cardiovascular and endocrine systems, the possible interaction between ATP and catecholamines in regulation of platelet reactivity has not been reported. The addition of ATP (1-5 µM) to human platelet-rich plasma did not induce platelet aggregation; however, it selectively augmented the aggregatory response to norepinephrine and epinephrine, but not to serotonin. This potentiating action of ATP was dose dependent and was not due to contamination by, or hydrolysis to, ADP. The action of ATP was blocked by 10 µM of adenosine 3'-phosphate 5'-phosphosulfate, a selective P2Y1 receptor antagonist. ATP alone did not cause release of intracellular Ca2+, but produced a significant Ca2+ response in the presence of norepinephrine. In contrast, the P2X1 receptor agonists P1,P6-diadenosine-5' hexophosphate and alpha ,beta -methylene-ATP had no effect on norepinephrine-induced platelet aggregation even when added at 100 µM. This synergistic interaction between ATP and norepinephrine in stimulating platelet aggregation may have significant clinical implications and suggests a prothrombotic role for ATP in stress.

norepinephrine; synergism


This article has been cited by other articles:


Home page
 Eur Heart JHome page
M. Gasparini, C. Menozzi, A. Proclemer, M. Landolina, S. Iacopino, A. Carboni, E. Lombardo, F. Regoli, M. Biffi, V. Burrone, et al.
A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD] study
Eur. Heart J., November 2, 2009; 30(22): 2758 - 2767.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online